KLRK1 and glioma: Weiss et al. [100] investigated NKG2D‐based CAR‐T cells in GBM mouse models and demonstrated robust IFN‐γ production, strong cytolytic activity, and the ability to migrate to the brain tumor site, extending survival and even curing some glioma‐bearing mice.